Cargando…

Selection of predicted siRNA as potential antiviral therapeutic agent against influenza virus

Influenza virus A (IVA) infection is responsible for recent death worldwide. Hence, there is a need to develop therapeutic agents against the virus. We describe the prediction of short interfering RNA (siRNA) as potential therapeutic molecules for the HA (Haemagglutinin) and NA (Neuraminidase) genes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raza, Asif, Shareef, Hira, Salim, Hira, Khushal, Rashid, Bokhari, Habib
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2011
Materias:	Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143396/ https://www.ncbi.nlm.nih.gov/pubmed/21814391

Ejemplares similares

Bioinformatics prediction of siRNAs as potential antiviral agents against dengue viruses
por: Villegas-Rosales, Paula M, et al.
Publicado: (2012)

Design of potential siRNA molecules for hepatitis delta virus gene silencing
por: Singh, Sarita, et al.
Publicado: (2012)

Design of potential siRNA molecules for T antigen gene silencing of Merkel Cell Polyomavirus
por: Hoque, Kazi Muhammad Ahasanul, et al.
Publicado: (2012)

Analysis of glycosylation motifs and glycosyltransferases in Bacteria and Archaea
por: Tabish, Syed, et al.
Publicado: (2011)

Computational analysis reveals abundance of potential glycoproteins in Archaea, Bacteria and Eukarya
por: Zafar, Sadia, et al.
Publicado: (2011)

Prediction of antiviral peptides derived from viral fusion proteins potentially active against herpes simplex and influenza A viruses
por: Jesús, Torres, et al.
Publicado: (2012)

Comparative analysis of organophosphate degrading enzymes from diverse species
por: Salman, Amna, et al.
Publicado: (2010)

Evidences of lateral gene transfer between archaea and pathogenic bacteria
por: Bokhari, Habib, et al.
Publicado: (2011)

Selection of herbal therapeutics against deltatoxin mediated Clostridial infections
por: Skariyachan, Sinosh, et al.
Publicado: (2011)

Receptor modification as a therapeutic approach against viral diseases
por: Farid, Rabia, et al.
Publicado: (2012)

Antiviral therapy: a perspective
por: Shahidi Bonjar, Amir Hashem
Publicado: (2016)

Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010)

siRNAs: Potential therapeutic agents against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011)

siRNA for Influenza Therapy
por: Barik, Sailen
Publicado: (2010)

A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitior
por: Zhang, Chuanfu, et al.
Publicado: (2010)

Molecular screening of phytochemicals from Amelanchier Alnifolia against HCV NS3 protease/helicase using computational docking techniques
por: Khan, Mahim, et al.
Publicado: (2013)

Influenza virus-flow from insects to humans as causative for influenza seasonality
por: Pfäfflin, Albrecht
Publicado: (2020)

Replicative Homeostasis III: implications for antiviral therapy and mechanisms of response and non-response
por: Sallie, Richard
Publicado: (2007)

How many antiviral small interfering RNAs may be encoded by the mammalian genomes?
por: Zabolotneva, Anastasia, et al.
Publicado: (2010)

Design of a new therapy for patients with chronic kidney disease: use of microarrays for selective hemoadsorption of uremic wastes and toxins to improve homeostasis
por: Shahidi Bonjar, Mohammad Rashid, et al.
Publicado: (2015)

Proposed lead molecules against Hemagglutinin of avian influenza virus (H5N1)
por: Nandi, Tannistha
Publicado: (2008)

Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase
por: Idrus, Syarifuddin, et al.
Publicado: (2012)

Lentiviral-mediated delivery of siRNAs for antiviral therapy
por: Morris, K V, et al.
Publicado: (2006)

A model system for antiviral siRNA therapeutics using exosome-based delivery
por: Wallen, Margaret, et al.
Publicado: (2022)

A model system for antiviral siRNA therapeutics using exosome-based delivery
por: Wallen, Margaret, et al.
Publicado: (2022)

Computer aided screening and evaluation of herbal therapeutics against MRSA infections
por: Skariyachan, Sinosh, et al.
Publicado: (2011)

Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development
por: Sankar, Sathish, et al.
Publicado: (2018)

Palindromes drive the re-assortment in Influenza A
por: Zubaer, Abdullah, et al.
Publicado: (2011)

Homology modelling of CB1 receptor and selection of potential inhibitor against Obesity
por: Shrinivasan, Mahesh, et al.
Publicado: (2012)

Identification of host encoded microRNAs interacting with novel swine-origin influenza A (H1N1) virus and swine influenza virus
por: He, Tao, et al.
Publicado: (2009)

Use of Hydrogen as a Novel Therapeutic Strategy Against Photoreceptor Degeneration in Retinitis Pigmentosa Patients
por: Tao, Ye, et al.
Publicado: (2016)

Screening and design of anti-diabetic compounds sourced from the leaves of neem (Azadirachta indica)
por: Jalil, Asma, et al.
Publicado: (2013)

Molecular designing and in silico evaluation of darunavir derivatives as anticancer agents
por: Mahto, Manoj kumar, et al.
Publicado: (2014)

Unique Bipolar Gene Architecture in the RNA Genome of Influenza A Virus
por: Zhirnov, O. P.
Publicado: (2020)

Designing Epitope Ensemble Vaccines against TB by Selection: Prioritizing Antigens using Predicted Immunogenicity
por: Mistry, Jaymisha, et al.
Publicado: (2017)

Modelling and simulation of mutant alleles of breast cancer metastasis suppressor 1 (BRMS1) gene
por: Adeel, Muhammad Muzammal, et al.
Publicado: (2014)

Therapeutic siRNA: state of the art
por: Hu, Bo, et al.
Publicado: (2020)

Pulmonary delivery of therapeutic siRNA
por: Lam, Jenny Ka-Wing, et al.
Publicado: (2012)

Drug Delivery of siRNA Therapeutics
por: Lamberti, Gaetano, et al.
Publicado: (2020)

A model to control the epidemic of H5N1 influenza at the source
por: Guan, Y, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_kfbo7o4uv4diohlmi7v01njm7i